Penumbra Inc (PEN)
236.43
+3.36
(+1.44%)
USD |
NYSE |
Nov 08, 16:00
236.43
0.00 (0.00%)
After-Hours: 20:00
Penumbra Revenue (Annual): 1.059B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.059B |
| December 31, 2022 | 847.13M |
| December 31, 2021 | 747.59M |
| December 31, 2020 | 560.41M |
| December 31, 2019 | 547.40M |
| December 31, 2018 | 444.94M |
| Date | Value |
|---|---|
| December 31, 2017 | 333.76M |
| December 31, 2016 | 263.32M |
| December 31, 2015 | 186.10M |
| December 31, 2014 | 125.51M |
| December 31, 2013 | 88.85M |
| December 31, 2012 | 73.14M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
547.40M
Minimum
2019
1.059B
Maximum
2023
752.21M
Average
747.59M
Median
2021
Revenue (Annual) Benchmarks
| Repligen Corp | 638.76M |
| Bruker Corp | 2.964B |
| Intuitive Surgical Inc | 7.124B |
| QuidelOrtho Corp | 2.998B |
| Inari Medical Inc | 493.63M |